Shreyas Kalantri/X
Aug 4, 2025, 14:54
Shreyas Kalantri: Engaging Insights on VTE Management
Shreyas Kalantri, Hematology and Oncology Chief Fellow at UofL Brown Cancer Center, shares an insight on VTE management on X:
”VTE management doesn’t stop at anticoagulation. Here are pearls to sharpen your heme boards prep and clinical instincts.
1. Thrombus extension after starting anticoagulation ≠ treatment failure.
Asymptomatic progression can happen in the first 1–2 weeks. No need to escalate therapy unless clinically indicated.”
Dr. Shreyas Kalantri offers engaging and thought‑provoking insights to help you refine and master your clinical reasoning—well worth following.
Stay tuned with Hemostasis Today.
-
Mar 1, 2026, 05:44Ilenia Calcaterra: Innovation In Rare Diseases Is Never Abstract
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?